Ozurdex, intravitreales Implantat in Applikator
7680603240015
CH-60324
intravitreales Implantat in Applikator
Associated product:
OZURDEX intravitréen implant dans applicateur
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Stück
- Galenic form
- intravitreales Implantat in Applikator
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
dexamethasonum
|
700.0 UG | Substance | Wirkstoff (Principe actif) |
|
poly(lactidum-co-glycolidum) 50/50 (0.16 - 0.24 dl/g) terminatum cum esteri
|
- | Substance | HNIDK |
|
poly(lactidum-co-glycolidum) 50/50 (0.16 - 0.24 dl/g)
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1051.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2012
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 60324
- Drug name
- Ozurdex, intravitreales Implantat in Applikator
- Galenic form
- IMPL
- ATC Code
- S01BA01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 10/01/2011
- Authorization expiration date
- 31/12/9999
- IT Number
- 11.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- OZURDEX intravitréen implant dans applicateur
- Description (DE)
- OZURDEX intravitreales Implant in Applikator
- Market launch
- 10/01/2011
- Narcotic (BTM)
- No